The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient Acquisition

疟原虫表面阴离子通道与疟原虫营养获取

基本信息

项目摘要

The Apicomplexan Molecular Physiology Section continued its studies of the plasmodial surface anion channel (PSAC) and made two significant contributions. First, we identified and characterized the first PSAC mutant (PNAS 104:1063-1068, 2007). This mutant was generated by in vitro selection with blasticidin S, a toxin that reaches its intracellular target via permeation through PSAC. Because blasticidin S resistance correlated with reduced permeability to multiple solutes, we predicted there may be marked changes in PSAC. Single-channel and whole-cell electrophysiology confirmed this prediction by revealing altered channel gating, selectivity, pharmacology, and functional copy number/infected cell. Mutant parasites cultured without blasticidin S reverted to the wild-type channel phenotype and exhibited restored susceptibility to killing by blasticidin S. These findings 1) confirm that PSAC is the primary mechanism of organic solute uptake after infection because changes in PSAC affected the permeability of each solute, 2) implicate parasite genes in the expression of PSAC because human erythrocytes lack heritable genetic material, 3) provide a new approach to cloning PSACs gene, 4) reveal a new drug resistance mechanism in malaria parasites, and 5) suggest that PSAC serves an essential role for the intracellular parasite because a fitness cost was associated with blasticidin S resistance. Second, we identified solute-inhibitor interactions within PSACs pore (Mol. Pharmacol. 71:1241-50, 2007). In this study, we found that phenyltrimethyl ammonium and isoleucine transport through PSAC were less effectively inhibited by known PSAC antagonists than the uptake of sorbitol and alanine. This observation was unexpected because all four solutes were thought to share a single transport mechanism. We excluded uptake via unrelated channels because specific PSAC inhibitors also exhibited solute-dependent affinities. Mixtures of permeating solutes, whole-cell electrophysiology, and temperature-dependence studies suggested that a single ion channel with two separate routes for permeating solutes is the most conservative explanation for our findings. Such a model may permit fine-tuning of PSACs unusual selectivity and allow the parasite to acquire a diverse collection of nutrients. These findings also suggest that PSAC antagonists must effectively block both routes to be suitable lead compounds for antimalarial drug development.
顶复门分子生理学组继续研究疟原虫表面阴离子通道(PSAC),并作出了两项重大贡献。 首先,我们鉴定并表征了第一个PSAC突变体(PNAS 104:1063-1068,2007)。 该突变体通过用杀稻瘟菌素S(一种通过渗透通过PSAC到达其细胞内靶标的毒素)进行体外选择而产生。 由于杀稻瘟菌素S抗性与对多种溶质的渗透性降低相关,因此我们预测PSAC可能存在显著变化。 单通道和全细胞电生理学通过揭示改变的通道门控、选择性、药理学和功能拷贝数/感染细胞证实了这一预测。 在没有杀稻瘟菌素S的情况下培养的突变寄生虫恢复到野生型通道表型,并表现出恢复的对杀稻瘟菌素S杀伤的敏感性。 这些发现1)证实了PSAC是感染后有机溶质摄取的主要机制,因为PSAC的变化影响了每种溶质的渗透性,2)由于人类红细胞缺乏可遗传的遗传物质,因此PSAC的表达涉及寄生虫基因,3)提供了克隆PSAC基因的新方法,4)揭示了疟疾寄生虫中新的耐药机制,和5)表明PSAC对于胞内寄生物起重要作用,因为适合度成本与杀稻瘟菌素S抗性相关。 其次,我们确定了PSAC孔内的溶质-抑制剂相互作用(Mol. Pharmacol. 71:1241-50,2007)。 在这项研究中,我们发现,苯三甲基铵和异亮氨酸运输通过PSAC被有效抑制已知的PSAC拮抗剂比山梨糖醇和丙氨酸的摄取。 这一观察结果是出乎意料的,因为人们认为所有四种溶质都具有单一的传输机制。 我们排除了通过不相关通道的摄取,因为特异性PSAC抑制剂也表现出溶质依赖性亲和力。 渗透溶质的混合物,全细胞电生理学和温度依赖性研究表明,一个单一的离子通道与两个独立的路线渗透溶质是我们的研究结果最保守的解释。 这样的模型可以允许PSAC不寻常的选择性微调,并允许寄生虫获得不同的营养素集合。 这些发现还表明,PSAC拮抗剂必须有效地阻断这两种途径,才能成为抗疟药物开发的合适先导化合物。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SANJAY A DESAI其他文献

SANJAY A DESAI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SANJAY A DESAI', 18)}}的其他基金

EXPRESSION OF THE PLASMODIAL NUTRIENT CHANNEL ON OOCYTES
卵母细胞上疟原虫营养通道的表达
  • 批准号:
    2057456
  • 财政年份:
    1994
  • 资助金额:
    $ 75.53万
  • 项目类别:
EXPRESSION OF THE PLASMODIAL NUTRIENT CHANNEL ON OOCYTES
卵母细胞上疟原虫营养通道的表达
  • 批准号:
    2057455
  • 财政年份:
    1994
  • 资助金额:
    $ 75.53万
  • 项目类别:
EXPRESSION OF THE PLASMODIAL NUTRIENT CHANNEL ON OOCYTES
卵母细胞上疟原虫营养通道的表达
  • 批准号:
    2057457
  • 财政年份:
    1994
  • 资助金额:
    $ 75.53万
  • 项目类别:
The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient Acquisition
疟原虫表面阴离子通道与疟原虫营养获取
  • 批准号:
    8946347
  • 财政年份:
  • 资助金额:
    $ 75.53万
  • 项目类别:
The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient Acquisition
疟原虫表面阴离子通道与疟原虫营养获取
  • 批准号:
    7732557
  • 财政年份:
  • 资助金额:
    $ 75.53万
  • 项目类别:
The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient Acquisition
疟原虫表面阴离子通道与疟原虫营养获取
  • 批准号:
    7964438
  • 财政年份:
  • 资助金额:
    $ 75.53万
  • 项目类别:
The Plasmodial Surface Anion Channel And Malaria Parasit
疟原虫表面阴离子通道与疟原虫
  • 批准号:
    6809114
  • 财政年份:
  • 资助金额:
    $ 75.53万
  • 项目类别:
Cellular and Molecular Physiology of Bloodstream Malaria Parasites
血流疟原虫的细胞和分子生理学
  • 批准号:
    10272080
  • 财政年份:
  • 资助金额:
    $ 75.53万
  • 项目类别:
Plasmodial Surface Anion Channel And Malaria Parasite
疟原虫表面阴离子通道与疟原虫
  • 批准号:
    6503692
  • 财政年份:
  • 资助金额:
    $ 75.53万
  • 项目类别:
The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient Acquisition
疟原虫表面阴离子通道与疟原虫营养获取
  • 批准号:
    8336147
  • 财政年份:
  • 资助金额:
    $ 75.53万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 75.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 75.53万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 75.53万
  • 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 75.53万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 75.53万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 75.53万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 75.53万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 75.53万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 75.53万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 75.53万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了